TL;DR
This study reveals that overexpressing two specific microRNAs, miR-183-5p and miR-492, in normal breast epithelial cells can induce pre-cancerous characteristics like increased proliferation, invasion, and loss of cell polarity. This suggests these miRNAs could act as "oncomiRs" and potential biomarkers for early breast cancer risk, particularly in young women.
What Problem Does This Paper Address?
Breast cancer is a significant health concern, especially in young women, with a high incidence in certain populations like Lebanon. While microRNAs (miRNAs) are known to play roles in cancer development and can serve as biomarkers, the specific miRNAs driving early stages of breast tumorigenesis and affecting epithelial cell organization remain an area of active research. This paper aims to identify key miRNAs involved in the loss of epithelial polarity, a crucial early event in cancer, and to understand their contribution to the development of pre-neoplastic phenotypes, particularly in the context of a specific genetic alteration (loss of Cx43) known to predispose to cancer.
Methods
The researchers utilized a sophisticated 3D cell culture model of breast epithelial risk progression (HMT-3522 S1 cells and their Cx43-silenced counterparts, Cx43-KO-S1). They employed miRNA sequencing to identify differentially expressed miRNAs between normal and pre-neoplastic cells. To investigate the functional role of specific miRNAs, they used lentiviral vectors for stable ectopic over-expression of miR-183-5p and miR-492 in the normal S1 cells. Key techniques for assessing phenotypic changes included:
- Immunofluorescence staining to visualize the localization of key proteins (Cx43, β-catenin, Scrib) involved in cell polarity.
- Confocal microscopy for detailed imaging of 3D cell structures (acini).
- RT-qPCR to validate miRNA expression levels.
- Cell counting assays (in both 2D and 3D cultures) to assess proliferation.
- Transwell invasion assays to measure the cells' ability to invade through a matrix.
- Ingenuity Pathway Analysis (IPA) to predict downstream targets and biological pathways affected by the miRNAs.
Datasets
The study utilized two primary sources of data:
- In vitro 3D cell culture model: miRNA sequencing data was generated from normal S1 cells and Cx43-KO-S1 cells.
- Human patient data: Tumor-associated miRNA data from a young Lebanese patient cohort with early-stage breast cancer, previously reported by Nassar et al. (2017), was used for comparative analysis. Data from The Cancer Genome Atlas (TCGA) was also referenced for comparison.
Key Insights and Ideas
- Loss of Cx43 as a trigger for pre-neoplastic phenotypes: The study builds upon previous work showing that silencing Cx43 in normal breast epithelial cells leads to pre-cancerous characteristics.
- miRNAs as drivers of these phenotypes: The research identifies specific miRNAs that are dysregulated upon Cx43 loss and, crucially, demonstrates that overexpressing these miRNAs alone can recapitulate these pre-neoplastic changes.
- miR-183-5p and miR-492 as key players: These two miRNAs emerged as significant candidates, with miR-183-5p being downstream of Cx43 loss and commonly found in both the cell model and patient samples, while miR-492 was specific to the Lebanese patient cohort.
- Disruption of epithelial polarity: A major finding is that overexpressing these miRNAs leads to a loss of normal cell organization, characterized by altered localization of key polarity proteins (Cx43, β-catenin, Scrib) and a decrease in nuclear circularity. This highlights the critical role of miRNAs in maintaining tissue architecture.
- OncomiRs and early cancer biomarkers: The study strongly suggests that miR-183-5p and miR-492 function as "oncomiRs" (miRNAs that promote cancer development) and could serve as early diagnostic biomarkers, particularly miR-492 in the young Lebanese population.
Key Results
- 65 differentially expressed miRNAs were identified upon Cx43 loss in the 3D culture model.
- Ectopic expression of miR-183-5p or miR-492 in S1 cells resulted in:
- Larger, multi-layered acini devoid of lumen.
- Disrupted epithelial polarity, evidenced by altered localization of Cx43, β-catenin, and Scrib.
- Decreased nuclear circularity.
- Enhanced proliferation in both 2D and 3D cultures.
- Increased invasion capacity.
- miR-183-5p was found to be downstream of Cx43 loss and commonly upregulated in the patient cohort and the 3D culture model.
- miR-492 was not attributed to Cx43 loss but was specifically upregulated in the young Lebanese patients.
- Survival analysis indicated that Cx43, miR-183-5p, and miR-492 have associations with disease prognosis, with miR-492 showing a significant association with poor prognosis when upregulated across all grades.
Limitations and Future Work
- In vitro model limitations: While the 3D culture model is sophisticated, it is still an in vitro system and may not fully replicate the complexity of the in vivo tumor microenvironment.
- Mechanistic validation: While IPA predicted downstream targets and pathways, further experimental validation of these specific targets for miR-183-5p and miR-492 is needed.
- Broader population studies: The specificity of miR-492 to the Lebanese cohort warrants further investigation in larger, diverse populations to confirm its diagnostic potential.
- Therapeutic potential: The study identifies miRNAs that drive pre-cancerous phenotypes, opening avenues for exploring them as therapeutic targets.
- Further investigation of gap junction involvement: The precise role of miR-183-5p and miR-492 in gap junction regulation, beyond altering Cx43 localization, requires further study.
- Comparison with transcriptome: Future work will focus on validating downstream mRNA targets and comparing the findings with the transcriptome of young Lebanese patients.
Summary updated